Evidence map›Paper›PMID 41760056›Full record

ArticleMedicine2026

Aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD) complicated with acute pancreatitis: A case report.

Siwei Luo, Yang Yang, Ting Long, Xiaoyan Guo

Abstract readCase Reports
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Siwei LuoDepartment of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.ORCID 0009-0003-9776-820
Yang Yang
Ting Long

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleNeuromyelitis optica spectrum disorders (NMOSD) is an autoimmune-mediated central nervous system (CNS) inflammatory demyelinating disease characterized by 6 major clinical syndromes, including myelitis, optic neuritis, area postrema syndrome, symptomatic cerebral syndrome, brainstem syndromes, and acute diencephalic clinical syndrome. PATIENT CONCERNS: A 32-year-old female, complaining of numbness in her right limb for 1 month, was diagnosed with aquaporin-4 antibody (AQP4-IgG)-positive NMOSD. She developed acute pancreatitis (AP) during disease relapse, representing a rare extra-neurological manifestation of NMOSD. DIAGNOSES: Spinal contrast-enhanced magnetic resonance imaging scan indicated hyperintense lesions on the T2-weighted sequence in the spinal cord at C2/C4 at the initial onset and extending from C2 to C6 vertebral levels at the recurrence of the disease. Serological profiling demonstrated a significant rise in AQP4-IgG titers (from 1:100 to 1:1000). During the recurrence of NMOSD, the patient manifested acute gastrointestinal symptoms, including severe epigastric pain with emesis. Laboratory tests revealed profound hyperamylasemia (amylase, 2293.8 U/L; pancreatic amylase, 1843.6 U/L). Abdominal computed tomography scan demonstrated definitive signs of AP, confirming the diagnosis.

interventionsShe received methylprednisolone and mycophenolate mofetil for NMOSD treatment. When AP occurred, she was placed on nil per os status and treated with gabexate and esomeprazole. OUTCOMES: The patient was discharged with relief of neurological dysfunction symptoms and maintained on nasojejunal tube feeding for nutritional support. Three months after discharge, clinical assessment revealed stable myelitis symptoms. There was no evidence of pancreatitis recurrence during the follow-up period. LESSONS: This case suggests that AQP4-IgG-mediated immune damage may not be confined to the CNS. There may be a possible association between NMOSD and AP in the pathophysiological mechanisms. AP may be a rare extra-CNS complication of NMOSD. Our case expands the spectrum of potential systemic complications in NMOSD, highlighting the need for increased clinical vigilance.

Indexed as

Aquaporin 4AutoantibodiesNeuromyelitis OpticaPancreatitisAcute DiseaseAdultFemaleHumansImmunoglobulin GMagnetic Resonance ImagingAQP4 protein, humanAquaporin 4AutoantibodiesImmunoglobulin Gacute pancreatitisAQP4aquaporin-4neuromyelitis optica spectrum disorderNMOSD

Identifiers

PMID41760056
PMCPMC12956181

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.